About Kaiser Permanente-Lone Tree
"Hours for departments and specialty care will vary. We are here to care for you virtually or in-person. Start by connecting with your care team online (visit our website) or by calling the Appointment and Advice Contact Center at 303-338-4545 or 1-800-218-1059 (TTY 711)."
Clinical Trials at Kaiser Permanente-Lone Tree
During the past decade, Kaiser Permanente-Lone Tree conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 24 clinical trials were completed, i.e. on
average, 43.6% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 22 clinical trials were completed. i.e. 146.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kaiser Permanente-Lone Tree" #1 sponsor was "National Cancer Institute (NCI)" with 40 trials, followed by "SWOG Cancer Research Network" with 13 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology"
with 3 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 9 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-Lone Tree"
#1 collaborator was "National Cancer Institute (NCI)" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Kaiser Permanente-Lone Tree
According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-Lone Tree" are
"Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Recurrent Ovarian Carcinoma" (4 trials), "Stage IV Cutaneous Melanoma AJCC v6 and v7" (4 trials) and "Breast Carcinoma" (3 trials). Many other conditions were trialed in "Kaiser Permanente-Lone Tree" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Permanente-Lone Tree
Most popular intervention types in "Kaiser Permanente-Lone Tree" are "Other" (53 trials), "Drug" (48 trials), "Biological" (32 trials), "Procedure" (21 trials) and "Radiation" (4 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (29 trials), "Quality-of-Life Assessment" (27 trials), "Biospecimen Collection" (16 trials), "Computed Tomography" (16 trials) and "Questionnaire Administration" (14 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Permanente-Lone Tree
The vast majority of trials in "Kaiser Permanente-Lone Tree" are
59 trials for "All" genders and 10 trials for "Female" genders.
Clinical Trials Status at Kaiser Permanente-Lone Tree
Currently, there are NaN active trials in "Kaiser Permanente-Lone Tree".
undefined are not yet recruiting,
14 are recruiting,
37 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 14 completed trials in Kaiser Permanente-Lone Tree,
1 suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Permanente-Lone Tree, 0 "Phase 1"
clinical trials were conducted, 23 "Phase 2" clinical
trials and 46 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".